China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- Lai condemned for citing 'threats' to call for hiking 'defense' spending
- Govt to soon allow private cars to enter Hong Kong from Guangdong
- Zhangjiajie National Forest Park emerges after rain like a fairyland
- Shanghai summer kicks off with 'Easy Go'
- Miao ethnic carnival in Hunan draws thousands
- Hebei roasted lamb contest blends history, tourism
